Viewing Study NCT03506802


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-01-25 @ 8:01 AM
Study NCT ID: NCT03506802
Status: WITHDRAWN
Last Update Posted: 2020-07-24
First Post: 2018-04-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HLA-A*0201 Positive Cells Present View
None NY-ESO-1 Positive Tumor Cells Present View
None Recurrent Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: